Genitourinary Cancer News

Colleen Tetzlaff, MHS, PA-C, has been named president of Association of Physician Assistants in Oncology.

Most cancer survivors reported experiencing some degree of sexual dysfunction after treatment, yet women were less likely than men to report being asked about sexual health by their health care provider, according to study results.

Single-fraction stereotactic body radiation therapy appeared safe and effective for patients with up to three oligometastatic lung tumors, according to results of the phase 2 SAFRON II trial presented at the virtual ASTRO Annual Meeting.

This year has seen some groundbreaking advances in genitourinary oncology, particularly in the fields of prostate, kidney and urothelial cancers.

Each month, John Sweetenham, MD, and I review a stack of reports from conferences and the international literature for reporting in HemOnc Today.

The overprescribing and overuse of antibiotics has been scrutinized in recent years due to the threat of antimicrobial resistance.

The FDA granted priority review to nivolumab in combination with cabozantinib for treatment of advanced renal cell carcinoma.

Prenatal proximity to certain commonly used pesticides appeared to increase testicular cancer risk later in life, according to study results.

The number of newly identified patients with six common types of cancer declined significantly soon after the COVID-19 pandemic began, according to data in a research letter published in JAMA Network Open.

The FDA granted breakthrough therapy designation to disitamab vedotin for treatment of certain patients with urothelial cancer, according to the agent’s manufacturer.